By Josh Beckerman
AquaBounty Technologies said third-quarter product revenue fell to $47,812 from $733,133, while net losses were narrower, primarily due to the sale of its Indiana fish farm.
AquaBounty, which had its first commercial-scale harvest of genetically engineered Atlantic salmon in 2021, said it is reviewing financing initiatives to maintain liquidity and has worked to reduce costs where appropriate.
Net loss was 88 cents a share, compared with a net loss of $1.60 a share a year earlier.
AquaBounty said in September that it would sell its Prince Edward Island facility.
The company says its land-based operations have environmental benefits including reducing imports and helping to protect wild salmon populations.
Stores including Whole Foods and Kroger have said over the years that they won't sell genetically engineered salmon. AquaBounty has noted retailer resistance and expressed more optimism about wholesale customers. Its products also include conventional Atlantic salmon eggs and salmon byproducts.
Shares were down 2.6% to $1.11 in recent trading.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
November 05, 2024 13:34 ET (18:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。